N-(6-(3-(dimethylamino)phenoxy)-3-(2-(4-fluoropiperidin-1-yl)-2-oxoethyl)-4-oxo-3,4-dihydroquinazolin-7-yl)-2-((4-(trifluoromethyl)benzyl)oxy)acetamide

ID: ALA4763527

PubChem CID: 162662060

Max Phase: Preclinical

Molecular Formula: C33H33F4N5O5

Molecular Weight: 655.65

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)c1cccc(Oc2cc3c(=O)n(CC(=O)N4CCC(F)CC4)cnc3cc2NC(=O)COCc2ccc(C(F)(F)F)cc2)c1

Standard InChI:  InChI=1S/C33H33F4N5O5/c1-40(2)24-4-3-5-25(14-24)47-29-15-26-27(38-20-42(32(26)45)17-31(44)41-12-10-23(34)11-13-41)16-28(29)39-30(43)19-46-18-21-6-8-22(9-7-21)33(35,36)37/h3-9,14-16,20,23H,10-13,17-19H2,1-2H3,(H,39,43)

Standard InChI Key:  BCUWSFGSHPDVGA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 47 51  0  0  0  0  0  0  0  0999 V2000
    9.0916  -22.2349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0905  -23.0619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8051  -23.4747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8032  -21.8222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5185  -22.2312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5218  -23.0641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2408  -23.4752    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9610  -23.0582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9576  -22.2254    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2340  -21.8096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2295  -20.9848    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.6705  -21.8108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3724  -23.4720    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3771  -21.8220    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6602  -23.0563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3773  -20.9973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3861  -22.2209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0912  -20.5894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0918  -19.7654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3772  -19.3520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6604  -19.7686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6633  -20.5912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6640  -22.2315    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9439  -23.4652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3886  -23.0457    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2317  -23.0495    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5154  -23.4586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8032  -23.0428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8061  -22.2209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0947  -21.8052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3776  -22.2143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3762  -23.0434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0883  -23.4552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6626  -21.8012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7231  -20.9607    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.9631  -22.3193    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.0398  -21.3326    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.9448  -19.3585    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0990  -21.8063    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9421  -18.5337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2319  -19.7732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8121  -22.2216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5231  -21.8106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5248  -20.9854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8093  -20.5730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0922  -20.9858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2418  -20.5741    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
  2 13  1  0
  1 14  1  0
 13 15  1  0
 14 16  1  0
 12 17  1  0
 16 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 16  1  0
 15 23  2  0
 15 24  1  0
 17 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
 34 35  1  0
 34 36  1  0
 34 37  1  0
 31 34  1  0
 21 38  1  0
 17 39  1  0
 38 40  1  0
 38 41  1  0
 39 42  1  0
 39 46  1  0
 42 43  1  0
 43 44  1  0
 44 45  1  0
 45 46  1  0
 44 47  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4763527

    ---

Associated Targets(Human)

NOD1 Tchem Nucleotide-binding oligomerization domain-containing protein 1 (1322 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NOD2 Tclin Nucleotide-binding oligomerization domain-containing protein 2 (1613 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 655.65Molecular Weight (Monoisotopic): 655.2418AlogP: 5.39#Rotatable Bonds: 10
Polar Surface Area: 106.00Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.14CX Basic pKa: 4.39CX LogP: 3.55CX LogD: 3.55
Aromatic Rings: 4Heavy Atoms: 47QED Weighted: 0.23Np Likeness Score: -1.59

References

1. Ma Y,Yang J,Wei X,Pei Y,Ye J,Li X,Si G,Tian J,Dong Y,Liu G.  (2020)  Nonpeptidic quinazolinone derivatives as dual nucleotide-binding oligomerization domain-like receptor 1/2 antagonists for adjuvant cancer chemotherapy.,  207  [PMID:32920426] [10.1016/j.ejmech.2020.112723]

Source